As of 2026-03-12, the Relative Valuation of ZIOPHARM Oncology Inc (ZIOP) is (8.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.87 USD, the upside of ZIOPHARM Oncology Inc based on Relative Valuation is -1133.3%.
The range of the Relative Valuation is (8.07) - (9.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 24.2x | 21.3x |
| Forward P/E multiples | 18.6x - 22.8x | 21.8x |
| Fair Price | (8.07) - (9.47) | (8.95) |
| Upside | -1032.1% - -1194.2% | -1133.3% |
| Date | P/E |